Patient | Age | Gender | Pathological stage | FGFR3 mutation | FGFR3 expression | Tumor size (cm) |
---|---|---|---|---|---|---|
T1 | 57 | Male | T1N1M1 | – | High | 10 |
T2 | 51 | Male | T3aN2M0 | – | Low | 2.5 |
T3 | 91 | Male | T2aN0M0 | – | Low | 1.3 |
T4 | 70 | Male | T1N0M1 | c.1138G > A | High | 1.1 |
T5 | 80 | Male | T2bN0M0 | – | Low | 4.9 |
T6 | 73 | Male | T4N2M1 | – | High | 4.0 |
T7 | 73 | Male | T3bN0M0 | – | High | 7.5 |
T8 | 70 | Male | T3aN0M0 | – | High | 4.0 |
T9 | 42 | Female | T3bN1M1 | – | High | 4.8 |
T10 | 66 | Female | T2aN0M0 | – | Low | 1.5 |
T11 | 48 | Male | T2aN0M0 | – | High | 1.0 |
T12 | 54 | Male | T3aN1M0 | – | High | 2.5 |